{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Temocapril , a long - acting non - SH group angiotensin converting enzyme inhibitor , modulates glomerular injury in chronic puromycin aminonucleoside nephrosis .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| chronic puromycin aminonucleoside nephrosis |\n\nExplanation:\n\nThe \"Disease\" entities in the given paragraph are those that refer to medical conditions or disorders. In this case, there is one such entity:\n\n* chronic puromycin aminonucleoside nephrosis: This is a medical condition that affects the kidneys and is caused by the administration of puromycin aminonucleoside. It is a chronic form of nephrosis, which is a type of kidney disease characterized by the loss of protein in the urine."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| chronic puromycin aminonucleoside nephrosis |\n\nExplanation:\n\nThe original paragraph mentions one medical condition, which is chronic puromycin aminonucleoside nephrosis. This is a disease that affects the kidneys and is caused by the administration of puromycin aminonucleoside. It is a chronic form of nephrosis, which is a type of kidney disease characterized by the loss of protein in the urine.\n\nThe other entities mentioned in the paragraph, such as \"Temocapril\" and \"angiotensin converting enzyme inhibitor,\" are not diseases, but rather drugs or classes of drugs used to treat medical conditions. Therefore, they are not included in the table."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Temocapril , a long - acting non - SH group angiotensin converting enzyme inhibitor , modulates glomerular injury in chronic puromycin aminonucleoside nephrosis .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Temocapril |\n| non - SH group |\n| angiotensin converting enzyme |\n| chronic puromycin aminonucleoside nephrosis |\n\nExplanation:\n\n1. Temocapril: A specific type of drug, mentioned by name.\n2. non - SH group: A type of chemical group that is being referred to in the context of angiotensin converting enzyme inhibitors.\n3. angiotensin converting enzyme: A well-known enzyme in the field of medicine and biology.\n4. chronic puromycin aminonucleoside nephrosis: A specific medical condition, mentioned by name, which is being studied in the context of the effects of Temocapril."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Temocapril |\n\nExplanation:\n\n1. Temocapril: A specific type of drug, mentioned by name, is the only clear chemical entity in the paragraph.\n2. non - SH group: This is not a clear chemical entity, as it is being used to describe a property of a group of chemical compounds.\n3. angiotensin converting enzyme: This is not a clear chemical entity, as it is a biological enzyme.\n4. chronic puromycin aminonucleoside nephrosis: This is not a clear chemical entity, as it is a medical condition."}
  ]
}